Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc

Bullboard Posts

Comment by stanleyon Jul 26, 2012 5:43pm

279 Views

Post# 20156817

RE: Big Mne in the Making.- Mill Capacity

Terry:

For those who were able to follow DR 's acquisition of the Stock Mill, it was probably his probably his "greatest contribution" to the advance of the Grey Fox project.

I believe that SAS plans to (staged)produce the 3,000 t/d maximize the feed to the Holt Mill . Is there a mill at Uranium City ? Sometimes it is worth it to relocate a mill than to build one from scratch.

BWDIK? It appears that the expansion of the Stock mill to ~ 3k then expand to 5k or build a separate 3k central to GF could be a possibility.

Cheers

Stanley

Bullboard Posts

StockTalk | Cannabis Report: New CEO, new dispensaries, new strains